Mi Young

Antitumor activity of HM781‐36B, a highly effective pan‐HER inhibitor in erlotinib‐resistant NSCLC and other EGFR‐dependent cancer models

Mi Young, Kwang‐Ok Lee, Mi‐Ra Kim et al. · International Journal of Cancer · 2011 · 79 citations · Full text

Medicine, Oncology, Pharmacology +13

Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor

Kwang‐Ok Lee, Mi Young, Mi‐Ra Kim et al. · Cancer Research · 2014 · 42 citations

Medicine, Oncology, Pharmacology +15

Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer

Mi Young, Kwang‐Ok Lee, Jong Woo Kim et al. · Journal of Medicinal Chemistry · 2009 · 37 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Synthesis and Biological Evaluation of Pyrimidine-Based Dual Inhibitors of Human Epidermal Growth Factor Receptor 1 (HER-1) and HER-2 Tyrosine Kinases

Mi Young, Kwang‐Ok Lee, Seok-Jong Kang et al. · Journal of Medicinal Chemistry · 2012 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Phenotypic Screening to Identify Small‐Molecule Enhancers for Glucose Uptake: Target Identification and Rational Optimization of Their Efficacy

Minseob Koh, Jongmin Park, Ja Young Koo et al. · Angewandte Chemie International Edition · 2014 · 24 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17